摘要
目的探讨经皮肝穿刺胆道支架植入术治疗恶性梗阻性黄疸的疗效。方法 45例患者采用经皮肝穿刺胆道引流术及内支架植入术治疗恶性梗阻性黄疸,其中胆管癌32例,胰头癌13例,术前及术后检查血清胆红素,观察减轻黄疸效果。结果 45例患者行经皮肝穿刺胆道支架植入术,支架植入成功42例,成功率93.3%,其中4例放置双支架。支架植入后扩张良好,胆汁引流通畅,术后1～4周血清胆红素下降明显(P<0.05),黄疸症状缓解明显。本组患者术后因腹腔内出血死亡1例,胆道出血2例,胆漏2例,胰腺炎3例,胆道感染8例。术后随访生存时间平均11.8个月,最长24个月。结论经皮肝穿刺胆道支架植入术是一种安全有效治疗恶性梗阻性黄疸的方法,明显延长患者生存时间、减轻患者痛苦、提高生存质量。
Objective To study and evaluate clinical efficacy of percutaneous transhepatic insertion of baliary stent in trea- ting malignant baliary obstructive jaundice. Methods 45 maligant obstructive jaundice patients were performed PTIBS, which in- cluded cholangiocarcinoma 32 cases and carcinoma of head of pancreas 13 cases. The total bilirubin（TBIL） were detected to ob- serve the efficacy of lessening jaundice. Results 42 patients were planted stent successed. The successful rate was 93.3% ,4 of them were inserted 2 stents. The stents opened well while the bile drainaged smoothly,TBIL decreased obviously after operation 1 to 4 weeks, the jaundice were relieved obviously. One case died because of abdominal cavity bleeding, hemobilia 2 cases, biliary leak 2 cases, pancreatitis 3 cases, the infection of baliary duct 8 cases. According to the follow-up,the mean survival time was 11. 8 months and the longest was 24 months. Conclusion PTBIS was a safe and effective treatment for maligant biliary obstructive patients and it prolonged the survival time and lessened the bitness and improved quality of life.
出处
《中华全科医学》
2013年第1期82-83,共2页
Chinese Journal of General Practice
关键词
经皮肝穿刺
支架
恶性胆管阻塞
黄疸
PTC （ percutaneous transhepatic cholangiography）
Stent
Maligant biliary obstruction
Jaundice
